Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

NGM Biopharmaceuticals Inc (was acquired by Atlas Neon Parent, Inc. on 05/04/2024) (NGM)

  • Event
  • June 30, 2022, 20:01 UTC
  • 12
  • 1 comments

(99% Neutral) NGM BIOPHARMACEUTICALS INC (NGM) Announces New Board Appointment

Comment Full text

Genmab (GMAB)

  • Event
  • June 30, 2022, 18:32 UTC
  • 10
  • 1 comments

(70% Positive) Genmab (GMAB) Announces Clinical Development Update (Form 6-K)

Comment Full text

Abcellera Biologics Inc (ABCL)

  • Event
  • June 30, 2022, 17:28 UTC
  • 11
  • 1 comments

(99% Neutral) ABCELLERA BIOLOGICS INC. (ABCL) Provides Update on authorized for an additional 350

Comment Full text

Sanofi (SNY)

  • Event
  • June 30, 2022, 16:10 UTC
  • 9
  • 1 comments

(85% Positive) Sanofi (SNY) Announces Clinical Development Update (Form 6-K)

Comment Full text

Cellectis (CLLS)

  • Event
  • June 30, 2022, 10:31 UTC
  • 9
  • 1 comments

(99% Neutral) Cellectis (CLLS) Files Form 6-K

Comment Full text

AstraZeneca (AZN)

  • Event
  • June 30, 2022, 10:27 UTC
  • 10
  • 1 comments

(90% Positive) AstraZeneca (AZN) Announces Clinical Development Update (Form 6-K)

Comment Full text

HUTCHMED DRC (HCM)

  • Event
  • June 30, 2022, 10:08 UTC
  • 10
  • 1 comments

(99% Neutral) HUTCHMED DRC (HCM) Files Form 6-K

Comment Full text

HUTCHMED DRC (HCM)

  • Event
  • June 29, 2022, 10:27 UTC
  • 10
  • 1 comments

(99% Neutral) HUTCHMED DRC (HCM) Files Form 6-K

Comment Full text

Cellectis (CLLS)

  • Event
  • June 28, 2022, 20:45 UTC
  • 10
  • 1 comments

(99% Neutral) Cellectis (CLLS) Announces Clinical Development Update (Form 6-K)

Comment Full text

Cellectis (CLLS)

  • Event
  • June 28, 2022, 20:17 UTC
  • 10
  • 1 comments

(99% Neutral) Cellectis (CLLS) Announces 2022 Annual General Meeting

Comment Full text
  • Previous
  • 169
  • 170
  • 171
  • 172
  • 173
  • Next

Search

News categories

  • Technical Exchange News(10870)
  • Event(2243)
  • SEC News(189156)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124509)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin